Expression and distribution of dendritic cells in nasal polyps

Experimental and Therapeutic Medicine

Volumn 5, Issue 5, 2013, Pages 1476-1480

  Lin, Xin Sheng ^a   Luo, Xian Yang ^b   Wang, Hui Ge ^c   Li, Chuang Wei ^a   Lin, Xin ^a   Yan, Chu ^a  

^a SHANTOU CENTRAL HOSPITAL   (China)

^b THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^c SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

CD1a; CD40; Dendritic cells; Nasal polyps; Pathogenesis; S 100 protein

Indexed keywords

CD40 ANTIGEN; PROTEIN S 100; T6 ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CELLULAR DISTRIBUTION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; FLUORESCENCE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NOSE POLYP; NOSE SEPTUM; PROTEIN EXPRESSION; T LYMPHOCYTE; TURBINATE;

EID: 84876522256     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.986     Document Type: Article

References (25)

1. Inaba K: Dendritic cells as antigen-presenting cells in vivo. Immunol Cell Biol 75: 206-208, 1997.
2. Watts C, Zaru R, Prescott AR, Wallin RP and West MA: Proximal effects of Toll-like receptor activation in dendritic cells. Curr Opin Immunol 19: 73-78, 2007.
3. Grewal IS, Foellmer HG, Grewal KD, et al: Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 273: 1864-1867, 1996.
4. Bernstein JM, Gorfien J, Noble B and Yankaskas JR: Nasal polyposis: immunohistochemistry and bioelectrical findings (a hypothesis for the development of nasal polyps). J Allergy Clin Immunol 99: 165-175, 1997.
5. Fan GK, Wang H and Takenaka H: Eosinophil infiltration and activation in nasal polyposis. Acta Otolaryngol 127: 521-526, 2007.
6. Hirschberg A, Jókúti A, Darvas Z, et al: The pathogenesis of nasal polyposis by immunoglobulin E and interleukin-5 is completed by transforming growth factor-beta1. Laryngoscope 113: 120-124, 2003.
7. Pawankar R: Nasal polyposis: an update: editorial review. Curr Opin Allergy Clin Immunol 3: 1-6, 2003.
8. Yoshimi R, Takamura H, Takasaki K and Kumagami H: Immunohistologic study of the nasal mucosa with reference to Langerhans cells. Nihon Jibiinkoka Gakkai Kaiho 96: 1252-1257, 1993 (In Japanese).
9. Drohan L, Harding JJ, Holm B, et al: Selective developmental defects of cord blood antigen-presenting cell subsets. Hum Immunol 65: 1356-1369, 2004.
10. Claeys S, de Belder T, Holtappels G, et al: Human beta-defensins and toll-like receptors in the upper airway. Allergy 58: 748-753, 2003.
11. Hao J, Pang YT and Wang DY: Diffuse mucosal inflammation in nasal polyps and adjacent middle turbinate. Otolaryngol Head Neck Surg 134: 267-275, 2006.
12. Morinaka S and Nakamura H: Inflammatory cells in nasal mucosa and nasal polyps. Auris Nasus Larynx 27: 59-64, 2000.
13. Woodworth BA, Joseph K, Kaplan AP and Schlosser RJ: Alterations in eotaxin, monocyte chemoattractant protein-4, interleukin-5, and interleukin-13 after systemic steroid treatment for nasal polyps. Otolaryngol Head Neck Surg 131: 585-589, 2004.
14. Villadangos JA and Schnorrer P: Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat Rev Immunol 7: 543-555, 2007.
15. Rissoan MC, Soumelis V, Kadowaki N, et al: Reciprocal control of T helper cell and dendritic cell differentiation. Science 283: 1183-1186, 1999.
16. Jahnsen FL, Lund-Johansen F, Dunne JF, Farkas L, Haye R and Brandtzaeg P: Experimentally induced recruitment of plasmacytoid (CD123high) dendritic cells in human nasal allergy. J Immunol 165: 4062-4068, 2000.
17. Redecke V, Häcker H, Datta SK, et al: Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol 172: 2739-2743, 2004.
18. Claeys S, de-Belder T, Holtappels G, et al: Human beta-defensins and toll-like receptors in the upper airway. Allergy 58: 748-753, 2003.
19. Kuchroo VK, Das MP, Brown JA, et al: B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80: 707-718, 1995.
20. Kelsall BL, Stüber E, Neurath M and Strober W: Interleukin-12 production by dendritic cells. The role of CD40-CD40L interactions in Th1 T-cell responses. Ann NY Acad Sci 795: 116-126, 1996.
21. Chen YS, Arab SF, Westhofen M and Lorenzen J: Expression of interleukin-5, interleukin-8, and interleukin-10 mRNA in the osteomeatal complex in nasal polyposis. Am J Rhinol 19: 117-123, 2005.
22. Reider N, Reider D, Ebner S, et al: Dendritic cells contribute to the development of atopy by an insufficiency in IL-12 production. J Allergy Clin Immunol 109: 89-95, 2002.
23. Sánchez-Segura A, Brieva JA and Rodriguez C: T lymphocytes that infiltrate nasal polyps have a specialized phenotype and produce a mixed TH1/TH2 pattern of cytokines. J Allergy Clin Immunol 6: 953-960, 1998.
24. Sokolovska A, Hem SL and HogenEsch H: Activation of dendritic cells and induction of CD4(+) T cell differentiation by aluminum-containing adjuvants. Vaccine 25: 4575-4585, 2007.
25. Yi H, Zhang L, Zhen Y, He X and Zhao Y: Dendritic cells induced in the presence of GM-CSF and IL-5. Cytokine 37: 35-43, 2007.